• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information.
 
DeviceSenza HFX iQ System, Senza HFX iQ IPG, HFX Trial Stimulator, HFX iQ Remote, HFX iQ Patient Application
Generic NameStimulator, spinal-cord, totally implanted for pain relief
ApplicantNevro Corporation
1800 Bridge Pkwy.
Redwood City, CA 94065
PMA NumberP130022
Supplement NumberS044
Date Received03/02/2022
Decision Date10/12/2022
Product Code LGW 
Advisory Committee Neurology
Supplement TypeNormal 180 Day Track
Supplement Reason Change Design/Components/Specifications/Material
Expedited Review Granted? No
Combination ProductNo
Predetermined Change Control Plan AuthorizedNo
Approval Order Statement  
Approval for a new Implantable Pulse Generator (IPG) system called the Senza HFX iQ system. The Senza HFX iQ system includes the following devices:1) Bluetooth enabled IPG called the HFX iQ IPG (IPG3000);2) Updated Senza Bluetooth Trial Stimulator called the HFX Trial Stimulator (TSM3500);3) Updated compatible Bluetooth Patient Remote called the HFX iQ Remote (PTR3000);4) New mobile device application software called as the HFX iQ Patient Application (PTA); 5) Updated Clinician Programmer software to configure the Bluetooth Trial Stimulators and Bluetooth IPG; and6) New software called as Gaea Cryptofunction that implements certain cybersecurity features of the Senza HFX iQ system.
-
-